Editorial: Medication-related osteonecrosis of the jaw (MRONJ): Bisphosphonates, antiresorptives, and antiangiogenic agents. What next? | Quintessence Publishing USA | Quintessence Publishing Company, Inc.

Dezember 15, 2015

DOI: 10.3290/j.qi.a35303, PubMed-ID: 26669747Seiten: 7-8, Sprache: EnglischMupparapu, Mel

Editorial: Medication-related osteonecrosis of the jaw (MRONJ): Bisphosphonates, antiresorptives, and antiangiogenic agents. What next?

Abonnement bestellen

Volltext Lesezeichen hinzufügen Endnote Export 0 Leseempfehlungen